Moonrise Medical key facts
- Developer of an artificial intelligence-enabled ultrasound technology designed to cater to the healthcare sector.
- It has raised $9.2M; the latest was Seed Round ($9.2M) in Jun 2025.
- Notable investors include Creative Destruction Lab, Government of Ontario, MedTech Angels, Providence Health Care Ventures, INOVAIT.
- Status: Privately Held (backing).
Who backs Moonrise Medical
5- ·Watch Moonrise Medical: the Monday email on marks, rounds and moves
Moonrise Medical funding rounds
No funding rounds for Moonrise Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Moonrise Medical investors
5 investors are on record for Moonrise Medical, including Creative Destruction Lab, Government of Ontario, MedTech Angels and Providence Health Care Ventures.
About Moonrise Medical
Developer of an artificial intelligence-enabled ultrasound technology designed to cater to the healthcare sector. The company offers an ultrasound-based device that aids in the diagnosis and evaluation of flow hemodynamics within the peripheral vascular system, with initial applications addressing peripheral artery disease (PAD) and diabetic foot ulcers (DFU), enabling patients to have an early diagnosis as well as receive guidance for treatment and interventions.
- Sector
- Healthcare
- HQ
- Hamilton, Canada
- Founded
- 2021
- Employees
- 10
- Website
- moonrisemedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Moonrise Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.